Use of 5-hydroxytryptamine 4 or 5-hydroxytryptamine 7 agonists to treat or prevent genetic or functional breathing rhythm disorders

摘要

5-hydroxytryptamine (HT) 4 or 5-HT7 agonists, e.g. buspar and 8-OH-DAP (8-hydroxy-2-dipropylaminotetralin), are used to treat or prevent genetic or functional breathing rhythm disorders.